Olmsted Syndrome
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome. (NCT07090889) | Orvida Pharma (formerly Kamari Pharma) | 2025-07-08 |
Track Olmsted Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.